Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| Trifluoroacetic Acid SCHEMBL3909280 | 0.85 | AGTR1 (0.42) | AGTR1AGTR2 | |
| SCHEMBL27904621 | 0.81 | AGTR1 (0.41) | AGTR1AGTR2 | |
| Trifluoroacetic Acid SCHEMBL3901768 | 0.78 | AGTR1 (0.33) | AGTR1AGTR2 | |
| SCHEMBL29183330 | 0.63 | AGTR1 (0.47) | AGTR1AGTR2 | |
| SCHEMBL3895319 | 0.62 | AGTR1 (0.39) | AGTR1AGTR2 | |
| Trifluoroacetic Acid SCHEMBL3908849 | 0.60 | NOTUM (0.40) | — | |
| SCHEMBL227 | 0.59 | AGTR1 (0.73) | AGTR1AGTR2 | |
| SCHEMBL3899533 | 0.58 | CPB1 (0.33) | — | |
| SCHEMBL29183326 | 0.58 | AGTR1 (0.45) | AGTR1AGTR2 | |
| SCHEMBL28705014 | 0.58 | SLC1A3 (0.33) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-7538128-B2 | Dipeptidyl peptidase IV inhibitors, process for their preparation and compositions containing them | GLENMARK PHARMACEUTICALS S.A. (CH) | 2009-05-26 | — | — | US | disclosed |
| US-20070238728-A1 | NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | GLENMARK PHARMACEUTICALS S.A. (CH) | 2007-10-11 | — | — | US | disclosed |
Patent text — is the patent's own abstract consistent with the prediction?
For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.
| Patent | Title | Text reads most about | Predicted target · text-rank |
|---|---|---|---|
| US-20070238728-A1 | NOVEL DIPEPTIDYL PEPTIDASE IV INHIBITORS, PROCESS FOR THEIR PREPARATION AND COMPOSITIONS CONTAINING THEM | DPP4, DPP3, DPP7 | AGTR1 60/4885AGTR2 103/4885 |
“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.